data_2jze_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jze _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 111.006 -0.838 . . . . 75.31 111.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 3.2 m -149.62 -28.02 0.26 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.386 1.874 . . . . 75.44 113.025 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -67.83 172.8 4.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.74 1.216 . . . . 72.45 112.172 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -163.58 0.95 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.595 2.358 . . . . 74.14 108.356 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' GLY . . . . . . . . . . . . . . . 96.92 157.55 31.06 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.898 -0.881 . . . . 73.32 110.898 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.7 m -65.74 147.7 52.96 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.072 1.349 . . . . 71.21 111.553 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.68 -177.95 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.874 1.67 . . . . 74.11 107.847 175.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' SER . . . . . . . . . . . . . 17.8 p -123.97 76.38 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.226 -1.398 . . . . 74.11 107.226 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -105.56 168.58 9.0 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.069 -0.715 . . . . 75.33 109.069 177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -107.53 176.57 5.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.854 -1.165 . . . . 72.23 107.854 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.74 -43.18 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.421 -0.799 . . . . 64.53 110.368 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.83 -54.23 37.31 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.53 0.605 . . . . 74.11 110.889 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.57 -40.68 84.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.655 0.782 . . . . 74.25 110.137 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 60.9 mtt -55.39 -52.65 62.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.446 0.566 . . . . 74.34 111.011 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.73 -45.65 89.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.54 1.136 . . . . 75.34 109.793 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -61.59 -52.1 65.81 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.243 1.017 . . . . 75.14 109.363 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -58.68 -50.57 73.4 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.481 1.512 . . . . 62.35 109.478 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' ALA . . . . . . . . . . . . . . . -55.14 -45.22 75.62 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.004 0.922 . . . . 65.22 111.517 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.12 -55.2 33.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.85 0.86 . . . . 72.33 111.131 173.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -64.43 -49.15 72.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.326 0.584 . . . . 75.12 110.246 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 70.9 p -75.0 -13.89 60.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.663 0.785 . . . . 74.31 112.285 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.69 8.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.344 1.857 . . . . 74.51 112.736 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -71.85 158.37 36.18 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.649 -1.282 . . . . 71.44 109.573 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' LEU . . . . . . . . . . . . . 6.0 tt -74.08 150.97 40.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.722 0.809 . . . . 65.12 108.893 -176.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' MET . . . . . . . . . . . . . 27.0 ttt -135.29 108.24 10.32 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 121.124 -0.985 . . . . 73.53 109.805 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.07 147.93 16.77 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.086 1.858 . . . . 71.14 113.581 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.56 121.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.405 1.882 . . . . 63.24 109.116 -174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' CYS . . . . . . . . . . . . . 4.4 t -74.56 107.25 6.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.641 -0.503 . . . . 72.22 109.641 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' MET . . . . . . . . . . . . . 28.8 mtp -53.58 -37.05 62.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.389 2.276 . . . . 65.42 113.49 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.74 -37.68 8.85 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.059 2.543 . . . . 71.54 111.187 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' VAL . . . . . . . . . . . . . 4.6 t -81.71 77.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 123.235 1.493 . . . . 72.35 107.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -61.54 -21.4 64.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.643 -1.162 . . . . 73.42 112.562 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.68 76.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.303 0.641 . . . . 74.45 112.65 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.09 -41.99 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.241 1.017 . . . . 74.45 108.338 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -52.94 58.69 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.233 -0.889 . . . . 64.23 109.768 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -54.45 -49.78 69.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.75 0.705 . . . . 61.24 110.985 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' THR . . . . . . . . . . . . . 18.8 m -51.81 -51.63 55.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.693 1.197 . . . . 74.31 111.542 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -49.84 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.674 -0.862 . . . . 74.32 108.674 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -58.09 -32.79 68.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.371 1.468 . . . . 75.43 112.468 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -59.97 -54.38 46.76 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.559 -0.713 . . . . 73.25 109.662 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -67.95 -60.93 2.12 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.333 -0.617 . . . . 64.13 109.333 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.41 76.48 4.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.805 2.042 . . . . 65.21 107.98 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.53 -35.81 17.95 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 120.723 -1.235 . . . . 74.13 112.528 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' GLY . . . . . . . . . . . . . . . -64.04 -17.87 61.66 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.967 0.803 . . . . 44.44 113.006 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ILE . . . . . 0.407 HG13 ' CG1' ' A' ' 574' ' ' VAL . 0.0 OUTLIER -79.13 129.27 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.738 -0.86 . . . . 74.31 109.98 168.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.18 129.43 34.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 105.377 -2.083 . . . . 74.15 105.377 164.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.8 133.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 120.186 1.357 . . . . 71.31 107.495 173.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 154.82 47.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.409 1.483 . . . . 74.32 107.85 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -76.04 126.1 30.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.087 -1.819 . . . . 75.42 106.087 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' GLY . . . . . . . . . . . . . . . 107.68 -167.97 13.77 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.622 1.106 . . . . 61.51 112.545 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 16.8 mm -59.44 123.78 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.987 1.315 . . . . 74.22 109.907 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' VAL . . . . . 0.407 ' CG1' HG13 ' A' ' 567' ' ' ILE . 58.6 t -128.49 87.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.22 -1.4 . . . . 73.12 107.22 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.07 99.64 3.97 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.244 -1.391 . . . . 61.33 107.244 170.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -152.0 101.18 2.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.228 -1.397 . . . . 74.32 107.228 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . 77.03 -68.63 2.57 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.924 -1.27 . . . . 72.24 109.924 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.64 147.25 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.976 -1.861 . . . . 62.14 105.976 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -82.91 78.56 9.48 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.672 -1.233 . . . . 73.33 107.672 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -77.4 161.48 27.97 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.064 -0.397 . . . . 72.42 111.455 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -140.51 87.69 2.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.023 1.329 . . . . 75.31 109.993 166.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.66 136.61 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.745 1.218 . . . . 74.43 108.224 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -144.13 161.68 38.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.625 0.726 . . . . 75.21 112.95 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 128.56 42.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.377 2.671 . . . . 71.22 109.094 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' SER . . . . . . . . . . . . . 82.2 p -68.62 -16.25 63.79 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.435 -1.416 . . . . 74.41 112.048 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -71.42 -24.54 62.06 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 117.544 -1.217 . . . . 74.32 111.399 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.94 143.38 97.38 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 119.538 1.063 . . . . 75.35 108.579 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.24 136.28 72.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.152 1.901 . . . . 75.11 109.298 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' VAL . . . . . 0.437 HG21 ' CD2' ' A' ' 613' ' ' HIS . 60.6 t -46.08 -44.22 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 169.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' ALA . . . . . . . . . . . . . . . -51.01 -58.72 5.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.968 1.307 . . . . 75.31 113.328 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 41.5 t -63.12 -46.52 86.93 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.343 -0.614 . . . . 65.32 109.343 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -37.81 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.391 -0.193 . . . . 75.24 111.309 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' ILE . . . . . . . . . . . . . 28.8 mt -59.94 -54.3 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.447 0.699 . . . . 72.41 110.045 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 6.0 m -46.16 -39.21 9.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.826 1.25 . . . . 72.54 113.079 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -68.24 -24.8 64.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.853 -1.155 . . . . 72.14 112.981 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.21 -37.93 32.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.194 0.906 . . . . 52.01 109.438 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.56 -39.06 92.46 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.636 0.774 . . . . 63.45 110.92 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 93.4 p -56.71 -44.74 81.87 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.153 0.981 . . . . 74.23 110.289 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.92 -32.79 69.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.045 1.338 . . . . 73.22 110.302 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 64.64 12.48 7.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.296 1.838 . . . . 72.24 111.539 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -78.8 145.1 65.66 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 123.557 0.743 . . . . 75.54 109.798 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -70.68 143.78 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.495 2.13 . . . . 71.11 111.108 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' LEU . . . . . . . . . . . . . 3.3 mt -125.69 172.31 9.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.623 0.725 . . . . 73.41 112.361 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.42 125.46 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.584 1.953 . . . . 75.21 105.959 162.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' THR . . . . . . . . . . . . . 4.5 t -165.12 -173.01 2.73 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.783 1.174 . . . . 72.32 110.096 170.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' MET . . . . . . . . . . . . . 3.2 ptt? -94.65 167.68 12.75 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.48 1.036 . . . . 74.23 108.83 164.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.87 140.32 79.12 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.05 1.833 . . . . 64.11 111.501 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 14.7 mm -76.35 -39.72 34.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.624 1.17 . . . . 74.51 111.454 -162.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -105.91 79.12 0.27 Allowed Glycine 0 C--O 1.204 -1.779 0 N-CA-C 106.746 -2.541 . . . . 72.14 106.746 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -124.97 -140.53 0.29 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.244 -1.761 . . . . 73.34 106.244 170.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' VAL . . . . . . . . . . . . . 91.1 t -38.15 -40.7 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.061 2.145 . . . . 64.34 111.618 168.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.9 p -61.12 -6.84 2.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.769 2.428 . . . . 62.22 114.664 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' HIS . . . . . 0.437 ' CD2' HG21 ' A' ' 589' ' ' VAL . 41.1 m80 -132.73 5.23 3.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 129.343 3.057 . . . . 73.33 111.824 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 66.79 22.62 72.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.554 1.07 . . . . 63.31 112.802 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.67 155.46 18.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.563 1.681 . . . . 74.33 109.845 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -82.88 159.31 22.39 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 113.998 -1.456 . . . . 72.43 110.175 166.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.95 -32.17 73.61 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.416 0.686 . . . . 75.54 111.317 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.3 -55.97 7.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.424 1.089 . . . . 75.32 110.653 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -54.96 -40.45 70.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.767 0.712 . . . . 75.51 111.403 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -55.03 -54.02 48.43 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.611 0.765 . . . . 72.22 110.492 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.53 73.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.894 -0.574 . . . . 74.35 110.033 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -52.1 -55.25 22.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.261 0.624 . . . . 74.14 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 t -62.77 -36.33 82.73 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.133 0.573 . . . . 74.52 110.616 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.264 0.0 OUTLIER -80.03 -15.39 57.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.321 -0.847 . . . . 74.51 112.959 -175.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -58.97 -27.32 65.25 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.878 1.217 . . . . 73.42 111.545 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 11.4 m -63.14 -6.84 4.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.981 0.912 . . . . 74.41 113.306 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.38 140.37 50.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.148 -0.97 . . . . 75.14 108.492 169.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -119.8 5.56 10.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.615 1.566 . . . . 74.41 111.408 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -104.89 148.96 36.98 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.144 1.377 . . . . 75.22 108.806 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.77 115.21 2.09 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.822 3.015 . . . . 63.45 111.61 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.11 151.74 50.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.675 -1.891 . . . . 72.54 112.35 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.02 134.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.706 -1.591 . . . . 72.21 106.706 164.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.09 164.89 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 106.452 -1.684 . . . . 62.12 106.452 171.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' SER . . . . . . . . . . . . . 6.1 t -129.44 176.42 7.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.741 1.155 . . . . 75.32 109.956 172.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.93 -179.79 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 127.164 2.186 . . . . 73.11 107.558 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' SER . . . . . . . . . . . . . 9.2 m -85.72 -9.19 57.53 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.552 0.945 . . . . 71.33 113.552 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 156.38 26.55 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 119.504 1.047 . . . . 74.23 110.141 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -64.03 -34.43 58.75 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.503 2.135 . . . . 73.14 112.696 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.7 -24.03 65.35 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.012 -1.055 . . . . 75.22 112.056 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' ALA . . . . . . . . . . . . . . . -77.36 -15.96 59.13 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.609 -0.682 . . . . 73.32 111.684 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.74 -57.37 12.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 124.598 1.159 . . . . 63.44 107.923 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' THR . . . . . . . . . . . . . 42.9 m -58.22 -37.81 75.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.575 1.15 . . . . 60.21 110.979 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' THR . . . . . . . . . . . . . 99.5 m -60.05 -57.24 13.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.628 0.771 . . . . 74.35 110.054 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -42.59 99.18 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.224 0.61 . . . . 73.22 111.619 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.56 -41.29 94.27 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.69 -0.631 . . . . 55.21 110.777 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -42.61 -45.69 5.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.022 1.296 . . . . 74.54 112.375 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -74.48 -32.17 62.47 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.277 -1.131 . . . . 74.11 112.069 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -25.91 65.66 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.64 0.978 . . . . 72.42 113.64 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -52.82 20.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.128 1.331 . . . . 53.44 108.435 161.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' SER . . . . . . . . . . . . . 5.8 p 43.69 73.44 0.15 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.207 1.003 . . . . 73.41 110.301 -159.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.254 0 C-N-CA 127.578 2.351 . . . . 51.34 111.012 -173.758 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 111.006 -0.838 . . . . 72.24 111.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 3.2 m -149.62 -28.02 0.26 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.386 1.874 . . . . 75.44 113.025 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -67.83 172.8 4.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.74 1.216 . . . . 72.11 112.172 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -163.58 0.95 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.595 2.358 . . . . 72.21 108.356 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 527' ' ' GLY . . . . . . . . . . . . . . . 96.92 157.55 31.06 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.898 -0.881 . . . . 61.34 110.898 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.7 m -65.74 147.7 52.96 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.072 1.349 . . . . 71.21 111.553 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 531' ' ' TRP . 34.6 m -138.68 -177.95 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.874 1.67 . . . . 64.13 107.847 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' SER . . . . . . . . . . . . . 17.8 p -123.97 76.38 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.226 -1.398 . . . . 74.11 107.226 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.404 ' CD2' HG21 ' A' ' 529' ' ' VAL . 51.9 m0 -105.56 168.58 9.0 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.069 -0.715 . . . . 73.44 109.069 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -107.53 176.57 5.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.854 -1.165 . . . . 64.55 107.854 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.74 -43.18 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.421 -0.799 . . . . 51.21 110.368 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.83 -54.23 37.31 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.53 0.605 . . . . 73.53 110.889 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.57 -40.68 84.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.655 0.782 . . . . 74.25 110.137 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 60.9 mtt -55.39 -52.65 62.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.446 0.566 . . . . 74.34 111.011 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.73 -45.65 89.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.54 1.136 . . . . 53.52 109.793 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -61.59 -52.1 65.81 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.243 1.017 . . . . 75.14 109.363 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -58.68 -50.57 73.4 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.481 1.512 . . . . 54.14 109.478 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 540' ' ' ALA . . . . . . . . . . . . . . . -55.14 -45.22 75.62 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.004 0.922 . . . . 65.22 111.517 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.12 -55.2 33.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.85 0.86 . . . . 72.33 111.131 173.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -64.43 -49.15 72.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.326 0.584 . . . . 72.23 110.246 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 70.9 p -75.0 -13.89 60.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.663 0.785 . . . . 64.53 112.285 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.69 8.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.344 1.857 . . . . 74.51 112.736 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -71.85 158.37 36.18 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.649 -1.282 . . . . 62.35 109.573 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 547' ' ' MET . 6.0 tt -74.08 150.97 40.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.722 0.809 . . . . 62.15 108.893 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 547' ' ' MET . . . . . 0.603 ' N ' HD23 ' A' ' 546' ' ' LEU . 27.0 ttt -135.29 108.24 10.32 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 121.124 -0.985 . . . . 73.53 109.805 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' PRO . . . . . 0.534 ' HG2' HG21 ' A' ' 605' ' ' THR . 72.4 Cg_endo -81.07 147.93 16.77 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.086 1.858 . . . . 61.42 113.581 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.56 121.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.405 1.882 . . . . 62.33 109.116 -174.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' CYS . . . . . . . . . . . . . 4.4 t -74.56 107.25 6.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.641 -0.503 . . . . 72.22 109.641 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' MET . . . . . . . . . . . . . 28.8 mtp -53.58 -37.05 62.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.389 2.276 . . . . 62.51 113.49 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.74 -37.68 8.85 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.059 2.543 . . . . 71.54 111.187 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' VAL . . . . . . . . . . . . . 4.6 t -81.71 77.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 123.235 1.493 . . . . 72.35 107.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -61.54 -21.4 64.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.643 -1.162 . . . . 62.34 112.562 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.68 76.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.303 0.641 . . . . 73.25 112.65 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.09 -41.99 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.241 1.017 . . . . 71.22 108.338 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -52.94 58.69 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.233 -0.889 . . . . 42.45 109.768 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -54.45 -49.78 69.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.75 0.705 . . . . 61.24 110.985 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' THR . . . . . . . . . . . . . 18.8 m -51.81 -51.63 55.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.693 1.197 . . . . 62.11 111.542 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 560' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -49.84 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.674 -0.862 . . . . 71.32 108.674 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -58.09 -32.79 68.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.371 1.468 . . . . 75.43 112.468 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 562' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -59.97 -54.38 46.76 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.559 -0.713 . . . . 73.25 109.662 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -67.95 -60.93 2.12 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.333 -0.617 . . . . 64.13 109.333 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.41 76.48 4.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.805 2.042 . . . . 65.21 107.98 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.53 -35.81 17.95 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 120.723 -1.235 . . . . 71.14 112.528 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' GLY . . . . . . . . . . . . . . . -64.04 -17.87 61.66 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.967 0.803 . . . . 43.01 113.006 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ILE . . . . . 0.499 HG13 ' CG1' ' A' ' 574' ' ' VAL . 0.0 OUTLIER -79.13 129.27 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.738 -0.86 . . . . 72.23 109.98 168.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.18 129.43 34.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 105.377 -2.083 . . . . 63.55 105.377 164.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 569' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.8 133.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 120.186 1.357 . . . . 71.31 107.495 173.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 570' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -130.25 154.82 47.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.409 1.483 . . . . 74.32 107.85 168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 571' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -76.04 126.1 30.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.087 -1.819 . . . . 75.42 106.087 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 572' ' ' GLY . . . . . . . . . . . . . . . 107.68 -167.97 13.77 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.622 1.106 . . . . 54.11 112.545 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 16.8 mm -59.44 123.78 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.987 1.315 . . . . 74.22 109.907 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 574' ' ' VAL . . . . . 0.499 ' CG1' HG13 ' A' ' 567' ' ' ILE . 58.6 t -128.49 87.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.22 -1.4 . . . . 61.34 107.22 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.07 99.64 3.97 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.244 -1.391 . . . . 31.44 107.244 170.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 576' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -152.0 101.18 2.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.228 -1.397 . . . . 71.11 107.228 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . 77.03 -68.63 2.57 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.924 -1.27 . . . . 72.24 109.924 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.64 147.25 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.976 -1.861 . . . . 62.14 105.976 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -82.91 78.56 9.48 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.672 -1.233 . . . . 71.21 107.672 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -77.4 161.48 27.97 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.064 -0.397 . . . . 72.42 111.455 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' PHE . . . . . 0.579 ' HB2' HD21 ' A' ' 546' ' ' LEU . 61.6 t80 -140.51 87.69 2.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.023 1.329 . . . . 73.23 109.993 166.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 582' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.66 136.61 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.745 1.218 . . . . 74.43 108.224 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -144.13 161.68 38.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.625 0.726 . . . . 75.21 112.95 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 128.56 42.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.377 2.671 . . . . 54.12 109.094 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 585' ' ' SER . . . . . . . . . . . . . 82.2 p -68.62 -16.25 63.79 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.435 -1.416 . . . . 62.42 112.048 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -71.42 -24.54 62.06 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 117.544 -1.217 . . . . 74.32 111.399 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 587' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.94 143.38 97.38 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 119.538 1.063 . . . . 54.43 108.579 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 588' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.24 136.28 72.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.152 1.901 . . . . 75.11 109.298 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 589' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 613' ' ' HIS . 60.6 t -46.08 -44.22 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.015 -0.735 . . . . 73.34 109.015 169.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 590' ' ' ALA . . . . . . . . . . . . . . . -51.01 -58.72 5.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.968 1.307 . . . . 63.13 113.328 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 41.5 t -63.12 -46.52 86.93 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.343 -0.614 . . . . 44.14 109.343 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -37.81 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.391 -0.193 . . . . 74.42 111.309 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 593' ' ' ILE . . . . . . . . . . . . . 28.8 mt -59.94 -54.3 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.447 0.699 . . . . 52.42 110.045 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 6.0 m -46.16 -39.21 9.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.826 1.25 . . . . 72.54 113.079 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -68.24 -24.8 64.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.853 -1.155 . . . . 41.53 112.981 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.21 -37.93 32.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.194 0.906 . . . . 44.01 109.438 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 597' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.56 -39.06 92.46 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.636 0.774 . . . . 44.41 110.92 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 93.4 p -56.71 -44.74 81.87 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.153 0.981 . . . . 60.14 110.289 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.92 -32.79 69.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.045 1.338 . . . . 73.22 110.302 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 64.64 12.48 7.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.296 1.838 . . . . 51.23 111.539 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -78.8 145.1 65.66 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 123.557 0.743 . . . . 74.54 109.798 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -70.68 143.78 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.495 2.13 . . . . 63.23 111.108 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' LEU . . . . . . . . . . . . . 3.3 mt -125.69 172.31 9.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.623 0.725 . . . . 33.34 112.361 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.42 125.46 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.584 1.953 . . . . 62.31 105.959 162.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 548' ' ' PRO . 4.5 t -165.12 -173.01 2.73 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.783 1.174 . . . . 61.33 110.096 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 606' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 605' ' ' THR . 3.2 ptt? -94.65 167.68 12.75 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.48 1.036 . . . . 74.15 108.83 164.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 607' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.87 140.32 79.12 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.05 1.833 . . . . 60.45 111.501 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 14.7 mm -76.35 -39.72 34.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.624 1.17 . . . . 53.45 111.454 -162.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -105.91 79.12 0.27 Allowed Glycine 0 C--O 1.204 -1.779 0 N-CA-C 106.746 -2.541 . . . . 54.15 106.746 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -124.97 -140.53 0.29 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.244 -1.761 . . . . 73.34 106.244 170.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 611' ' ' VAL . . . . . . . . . . . . . 91.1 t -38.15 -40.7 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.061 2.145 . . . . 62.11 111.618 168.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.9 p -61.12 -6.84 2.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.769 2.428 . . . . 62.22 114.664 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' HIS . . . . . 0.417 ' CD2' HG23 ' A' ' 589' ' ' VAL . 41.1 m80 -132.73 5.23 3.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 129.343 3.057 . . . . 65.54 111.824 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 66.79 22.62 72.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.554 1.07 . . . . 63.31 112.802 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.67 155.46 18.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.563 1.681 . . . . 63.23 109.845 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -82.88 159.31 22.39 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 113.998 -1.456 . . . . 60.44 110.175 166.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.95 -32.17 73.61 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.416 0.686 . . . . 75.54 111.317 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 618' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.3 -55.97 7.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.424 1.089 . . . . 44.41 110.653 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -54.96 -40.45 70.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.767 0.712 . . . . 61.21 111.403 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -55.03 -54.02 48.43 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.611 0.765 . . . . 52.31 110.492 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.53 73.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.894 -0.574 . . . . 52.32 110.033 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 622' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -52.1 -55.25 22.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.261 0.624 . . . . 72.51 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 t -62.77 -36.33 82.73 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.133 0.573 . . . . 73.42 110.616 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.264 0.0 OUTLIER -80.03 -15.39 57.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.321 -0.847 . . . . 74.51 112.959 -175.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -58.97 -27.32 65.25 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.878 1.217 . . . . 73.42 111.545 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 11.4 m -63.14 -6.84 4.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.981 0.912 . . . . 74.41 113.306 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.38 140.37 50.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.148 -0.97 . . . . 75.14 108.492 169.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -119.8 5.56 10.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.615 1.566 . . . . 63.52 111.408 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -104.89 148.96 36.98 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.144 1.377 . . . . 75.22 108.806 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.77 115.21 2.09 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.822 3.015 . . . . 54.31 111.61 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.11 151.74 50.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.675 -1.891 . . . . 33.23 112.35 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.02 134.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.706 -1.591 . . . . 64.25 106.706 164.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.09 164.89 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 106.452 -1.684 . . . . 41.13 106.452 171.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 634' ' ' SER . . . . . 0.435 ' H ' ' HA ' ' A' ' 606' ' ' MET . 6.1 t -129.44 176.42 7.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.741 1.155 . . . . 75.32 109.956 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.93 -179.79 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 127.164 2.186 . . . . 63.12 107.558 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' SER . . . . . . . . . . . . . 9.2 m -85.72 -9.19 57.53 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.552 0.945 . . . . 71.33 113.552 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 156.38 26.55 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 119.504 1.047 . . . . 34.1 110.141 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 638' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -64.03 -34.43 58.75 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.503 2.135 . . . . 73.14 112.696 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.7 -24.03 65.35 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.012 -1.055 . . . . 75.22 112.056 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' ALA . . . . . . . . . . . . . . . -77.36 -15.96 59.13 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.609 -0.682 . . . . 73.32 111.684 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.74 -57.37 12.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 124.598 1.159 . . . . 63.44 107.923 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 642' ' ' THR . . . . . . . . . . . . . 42.9 m -58.22 -37.81 75.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.575 1.15 . . . . 60.21 110.979 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 643' ' ' THR . . . . . . . . . . . . . 99.5 m -60.05 -57.24 13.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.628 0.771 . . . . 55.45 110.054 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -42.59 99.18 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.224 0.61 . . . . 73.22 111.619 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.56 -41.29 94.27 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.69 -0.631 . . . . 55.21 110.777 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -42.61 -45.69 5.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.022 1.296 . . . . 71.43 112.375 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -74.48 -32.17 62.47 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.277 -1.131 . . . . 74.11 112.069 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -25.91 65.66 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.64 0.978 . . . . 72.42 113.64 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -52.82 20.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.128 1.331 . . . . 53.44 108.435 161.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' SER . . . . . . . . . . . . . 5.8 p 43.69 73.44 0.15 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.207 1.003 . . . . 33.24 110.301 -159.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.254 0 C-N-CA 127.578 2.351 . . . . 51.34 111.012 -173.758 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 111.006 -0.838 . . . . 72.239999999999995 111.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' SER . . . . . . . . . . . . . 3.2 m -149.62 -28.02 0.26 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.386 1.874 . . . . 75.439999999999998 113.025 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -67.83 172.8 4.97 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.74 1.216 . . . . 72.109999999999999 112.172 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -118.06 -163.58 0.95 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 127.595 2.358 . . . . 72.209999999999994 108.356 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' GLY . . . . . . . . . . . . . . . 96.92 157.55 31.06 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.898 -0.881 . . . . 61.340000000000003 110.898 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' THR . . . . . . . . . . . . . 3.7 m -65.74 147.7 52.96 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.072 1.349 . . . . 71.209999999999994 111.553 -173.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' VAL . . . . . 0.404 HG21 ' CD2' ' A' ' 531' ' ' TRP . 34.6 m -138.68 -177.95 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.874 1.67 . . . . 64.129999999999995 107.847 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' SER . . . . . . . . . . . . . 17.8 p -123.97 76.38 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.226 -1.398 . . . . 74.109999999999999 107.226 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.404 ' CD2' HG21 ' A' ' 529' ' ' VAL . 51.9 m0 -105.56 168.58 9.0 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.069 -0.715 . . . . 73.439999999999998 109.069 177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ASN . . . . . . . . . . . . . 45.0 p-10 -107.53 176.57 5.11 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.854 -1.165 . . . . 64.549999999999997 107.854 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -54.74 -43.18 72.45 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.421 -0.799 . . . . 51.210000000000001 110.368 178.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -52.83 -54.23 37.31 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.53 0.605 . . . . 73.530000000000001 110.889 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -67.57 -40.68 84.89 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.655 0.782 . . . . 74.25 110.137 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 60.9 mtt -55.39 -52.65 62.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.446 0.566 . . . . 74.340000000000003 111.011 171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.73 -45.65 89.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 124.54 1.136 . . . . 53.520000000000003 109.793 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -61.59 -52.1 65.81 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.243 1.017 . . . . 75.140000000000001 109.363 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -58.68 -50.57 73.4 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 125.481 1.512 . . . . 54.140000000000001 109.478 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' ALA . . . . . . . . . . . . . . . -55.14 -45.22 75.62 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.004 0.922 . . . . 65.219999999999999 111.517 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.12 -55.2 33.77 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.85 0.86 . . . . 72.329999999999998 111.131 173.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -64.43 -49.15 72.63 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 121.326 0.584 . . . . 72.230000000000004 110.246 -173.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' THR . . . . . . . . . . . . . 70.9 p -75.0 -13.89 60.55 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.663 0.785 . . . . 64.530000000000001 112.285 -175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.69 8.68 0.96 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.344 1.857 . . . . 74.510000000000005 112.736 -167.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' LYS . . . . . . . . . . . . . 60.7 mttt -71.85 158.37 36.18 Favored 'General case' 0 C--O 1.233 0.191 0 O-C-N 120.649 -1.282 . . . . 62.350000000000001 109.573 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 547' ' ' MET . 6.0 tt -74.08 150.97 40.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.722 0.809 . . . . 62.149999999999999 108.893 -176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' MET . . . . . 0.603 ' N ' HD23 ' A' ' 546' ' ' LEU . 27.0 ttt -135.29 108.24 10.32 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 121.124 -0.985 . . . . 73.530000000000001 109.805 176.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' PRO . . . . . 0.534 ' HG2' HG21 ' A' ' 605' ' ' THR . 72.4 Cg_endo -81.07 147.93 16.77 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.086 1.858 . . . . 61.420000000000002 113.581 174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' ILE . . . . . . . . . . . . . 4.7 mp -137.56 121.89 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 126.405 1.882 . . . . 62.329999999999998 109.116 -174.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' CYS . . . . . . . . . . . . . 4.4 t -74.56 107.25 6.57 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.641 -0.503 . . . . 72.219999999999999 109.641 170.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' MET . . . . . . . . . . . . . 28.8 mtp -53.58 -37.05 62.56 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.389 2.276 . . . . 62.509999999999998 113.49 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -46.74 -37.68 8.85 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.059 2.543 . . . . 71.540000000000006 111.187 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' VAL . . . . . . . . . . . . . 4.6 t -81.71 77.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-O 123.235 1.493 . . . . 72.349999999999994 107.869 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 24.9 mtt180 -61.54 -21.4 64.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.643 -1.162 . . . . 62.340000000000003 112.562 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ALA . . . . . . . . . . . . . . . -61.74 -34.68 76.25 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.303 0.641 . . . . 73.25 112.65 170.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' ILE . . . . . . . . . . . . . 96.5 mt -78.09 -41.99 27.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.241 1.017 . . . . 71.219999999999999 108.338 172.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -53.79 -52.94 58.69 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 118.233 -0.889 . . . . 42.450000000000003 109.768 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -54.45 -49.78 69.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.75 0.705 . . . . 61.240000000000002 110.985 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' THR . . . . . . . . . . . . . 18.8 m -51.81 -51.63 55.1 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.693 1.197 . . . . 62.109999999999999 111.542 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' ILE . . . . . . . . . . . . . 67.7 mt -69.88 -49.84 53.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.674 -0.862 . . . . 71.319999999999993 108.674 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -58.09 -32.79 68.4 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.371 1.468 . . . . 75.430000000000007 112.468 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' ARG . . . . . . . . . . . . . 14.5 mtp180 -59.97 -54.38 46.76 Favored 'General case' 0 C--O 1.233 0.211 0 O-C-N 121.559 -0.713 . . . . 73.25 109.662 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -67.95 -60.93 2.12 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 109.333 -0.617 . . . . 64.129999999999995 109.333 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -93.41 76.48 4.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.805 2.042 . . . . 65.209999999999994 107.98 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -87.53 -35.81 17.95 Favored 'General case' 0 C--N 1.341 0.229 0 O-C-N 120.723 -1.235 . . . . 71.140000000000001 112.528 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' GLY . . . . . . . . . . . . . . . -64.04 -17.87 61.66 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.967 0.803 . . . . 43.009999999999998 113.006 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ILE . . . . . 0.499 HG13 ' CG1' ' A' ' 574' ' ' VAL . 0.0 OUTLIER -79.13 129.27 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 O-C-N 121.738 -0.86 . . . . 72.230000000000004 109.98 168.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.18 129.43 34.5 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 105.377 -2.083 . . . . 63.549999999999997 105.377 164.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' ILE . . . . . . . . . . . . . 29.8 mm -57.8 133.49 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 120.186 1.357 . . . . 71.310000000000002 107.495 173.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.25 154.82 47.2 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 125.409 1.483 . . . . 74.319999999999993 107.85 168.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -76.04 126.1 30.36 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 106.087 -1.819 . . . . 75.420000000000002 106.087 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' GLY . . . . . . . . . . . . . . . 107.68 -167.97 13.77 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 124.622 1.106 . . . . 54.109999999999999 112.545 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ILE . . . . . . . . . . . . . 16.8 mm -59.44 123.78 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.987 1.315 . . . . 74.219999999999999 109.907 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' VAL . . . . . 0.499 ' CG1' HG13 ' A' ' 567' ' ' ILE . 58.6 t -128.49 87.59 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 107.22 -1.4 . . . . 61.340000000000003 107.22 172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -75.07 99.64 3.97 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.244 -1.391 . . . . 31.440000000000001 107.244 170.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -152.0 101.18 2.71 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 107.228 -1.397 . . . . 71.109999999999999 107.228 173.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . 77.03 -68.63 2.57 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 109.924 -1.27 . . . . 72.239999999999995 109.924 -177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' VAL . . . . . . . . . . . . . 21.2 t -109.64 147.25 14.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 105.976 -1.861 . . . . 62.140000000000001 105.976 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' ARG . . . . . . . . . . . . . 51.7 ttt85 -82.91 78.56 9.48 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 107.672 -1.233 . . . . 71.209999999999994 107.672 -173.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -77.4 161.48 27.97 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.064 -0.397 . . . . 72.420000000000002 111.455 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' PHE . . . . . 0.579 ' HB2' HD21 ' A' ' 546' ' ' LEU . 61.6 t80 -140.51 87.69 2.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.023 1.329 . . . . 73.230000000000004 109.993 166.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -72.66 136.61 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.745 1.218 . . . . 74.430000000000007 108.224 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -144.13 161.68 38.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.625 0.726 . . . . 75.209999999999994 112.95 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.4 128.56 42.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.377 2.671 . . . . 54.119999999999997 109.094 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' SER . . . . . . . . . . . . . 82.2 p -68.62 -16.25 63.79 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.435 -1.416 . . . . 62.420000000000002 112.048 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -71.42 -24.54 62.06 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 117.544 -1.217 . . . . 74.319999999999993 111.399 176.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.94 143.38 97.38 Favored Pre-proline 0 C--O 1.239 0.535 0 CA-C-N 119.538 1.063 . . . . 54.43 108.579 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -55.24 136.28 72.71 Favored 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.152 1.901 . . . . 75.109999999999999 109.298 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' VAL . . . . . 0.417 HG23 ' CD2' ' A' ' 613' ' ' HIS . 60.6 t -46.08 -44.22 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.015 -0.735 . . . . 73.340000000000003 109.015 169.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' ALA . . . . . . . . . . . . . . . -51.01 -58.72 5.34 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.968 1.307 . . . . 63.130000000000003 113.328 175.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' SER . . . . . . . . . . . . . 41.5 t -63.12 -46.52 86.93 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 109.343 -0.614 . . . . 44.140000000000001 109.343 -176.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.78 -37.81 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 122.391 -0.193 . . . . 74.420000000000002 111.309 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' ILE . . . . . . . . . . . . . 28.8 mt -59.94 -54.3 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 123.447 0.699 . . . . 52.420000000000002 110.045 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 6.0 m -46.16 -39.21 9.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.826 1.25 . . . . 72.540000000000006 113.079 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' LYS . . . . . . . . . . . . . 34.7 mttt -68.24 -24.8 64.95 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 120.853 -1.155 . . . . 41.530000000000001 112.981 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' LEU . . . . . . . . . . . . . 25.8 mt -80.21 -37.93 32.14 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 119.194 0.906 . . . . 44.009999999999998 109.438 169.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -62.56 -39.06 92.46 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.636 0.774 . . . . 44.409999999999997 110.92 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' SER . . . . . . . . . . . . . 93.4 p -56.71 -44.74 81.87 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.153 0.981 . . . . 60.140000000000001 110.289 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.92 -32.79 69.82 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.045 1.338 . . . . 73.219999999999999 110.302 -177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 64.64 12.48 7.58 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 126.296 1.838 . . . . 51.229999999999997 111.539 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -78.8 145.1 65.66 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 123.557 0.743 . . . . 74.540000000000006 109.798 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -70.68 143.78 47.33 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 122.495 2.13 . . . . 63.229999999999997 111.108 174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' LEU . . . . . . . . . . . . . 3.3 mt -125.69 172.31 9.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.623 0.725 . . . . 33.340000000000003 112.361 -171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' VAL . . . . . . . . . . . . . 2.4 p -145.42 125.46 6.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.584 1.953 . . . . 62.310000000000002 105.959 162.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' THR . . . . . 0.534 HG21 ' HG2' ' A' ' 548' ' ' PRO . 4.5 t -165.12 -173.01 2.73 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.783 1.174 . . . . 61.329999999999998 110.096 170.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' MET . . . . . 0.458 ' O ' HG23 ' A' ' 605' ' ' THR . 3.2 ptt? -94.65 167.68 12.75 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.48 1.036 . . . . 74.150000000000006 108.83 164.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -62.87 140.32 79.12 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.05 1.833 . . . . 60.450000000000003 111.501 -166.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' ILE . . . . . . . . . . . . . 14.7 mm -76.35 -39.72 34.55 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 124.624 1.17 . . . . 53.450000000000003 111.454 -162.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' GLY . . . . . . . . . . . . . . . -105.91 79.12 0.27 Allowed Glycine 0 C--O 1.204 -1.779 0 N-CA-C 106.746 -2.541 . . . . 54.149999999999999 106.746 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -124.97 -140.53 0.29 Allowed 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.244 -1.761 . . . . 73.340000000000003 106.244 170.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' VAL . . . . . . . . . . . . . 91.1 t -38.15 -40.7 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 C-N-CA 127.061 2.145 . . . . 62.109999999999999 111.618 168.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' THR . . . . . . . . . . . . . 16.9 p -61.12 -6.84 2.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.769 2.428 . . . . 62.219999999999999 114.664 174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' HIS . . . . . 0.417 ' CD2' HG23 ' A' ' 589' ' ' VAL . 41.1 m80 -132.73 5.23 3.94 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 129.343 3.057 . . . . 65.540000000000006 111.824 173.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' GLY . . . . . . . . . . . . . . . 66.79 22.62 72.05 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 119.554 1.07 . . . . 63.310000000000002 112.802 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -90.67 155.46 18.82 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 119.563 1.681 . . . . 63.229999999999997 109.845 -174.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -82.88 159.31 22.39 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 113.998 -1.456 . . . . 60.439999999999998 110.175 166.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' LEU . . . . . . . . . . . . . 37.4 tp -63.95 -32.17 73.61 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.416 0.686 . . . . 75.540000000000006 111.317 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -70.3 -55.97 7.89 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.424 1.089 . . . . 44.409999999999997 110.653 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -54.96 -40.45 70.02 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 118.767 0.712 . . . . 61.210000000000001 111.403 172.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' ALA . . . . . . . . . . . . . . . -55.03 -54.02 48.43 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.611 0.765 . . . . 52.310000000000002 110.492 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' ALA . . . . . . . . . . . . . . . -59.35 -50.53 73.62 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 118.894 -0.574 . . . . 52.32 110.033 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' ARG . . . . . . . . . . . . . 42.4 mtm-85 -52.1 -55.25 22.01 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.261 0.624 . . . . 72.510000000000005 110.619 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' CYS . . . . . . . . . . . . . 4.3 t -62.77 -36.33 82.73 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 123.133 0.573 . . . . 73.420000000000002 110.616 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.264 0.0 OUTLIER -80.03 -15.39 57.3 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 118.321 -0.847 . . . . 74.510000000000005 112.959 -175.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -58.97 -27.32 65.25 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.878 1.217 . . . . 73.420000000000002 111.545 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' SER . . . . . . . . . . . . . 11.4 m -63.14 -6.84 4.64 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.981 0.912 . . . . 74.409999999999997 113.306 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' LEU . . . . . . . . . . . . . 8.5 tp -71.38 140.37 50.14 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.148 -0.97 . . . . 75.140000000000001 108.492 169.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -119.8 5.56 10.96 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.615 1.566 . . . . 63.520000000000003 111.408 -176.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' ALA . . . . . . . . . . . . . . . -104.89 148.96 36.98 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.144 1.377 . . . . 75.219999999999999 108.806 172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -83.77 115.21 2.09 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 123.822 3.015 . . . . 54.310000000000002 111.61 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' ALA . . . . . . . . . . . . . . . -135.11 151.74 50.99 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.675 -1.891 . . . . 33.229999999999997 112.35 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' VAL . . . . . . . . . . . . . 73.3 t -82.02 134.7 26.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 106.706 -1.591 . . . . 64.25 106.706 164.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.09 164.89 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 106.452 -1.684 . . . . 41.130000000000003 106.452 171.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' SER . . . . . 0.435 ' H ' ' HA ' ' A' ' 606' ' ' MET . 6.1 t -129.44 176.42 7.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 119.741 1.155 . . . . 75.319999999999993 109.956 172.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' VAL . . . . . . . . . . . . . 1.3 m -145.93 -179.79 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.477 0 C-N-CA 127.164 2.186 . . . . 63.119999999999997 107.558 171.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' SER . . . . . . . . . . . . . 9.2 m -85.72 -9.19 57.53 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.552 0.945 . . . . 71.329999999999998 113.552 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -158.92 156.38 26.55 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 119.504 1.047 . . . . 34.100000000000001 110.141 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -64.03 -34.43 58.75 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.503 2.135 . . . . 73.140000000000001 112.696 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -67.7 -24.03 65.35 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 121.012 -1.055 . . . . 75.219999999999999 112.056 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' ALA . . . . . . . . . . . . . . . -77.36 -15.96 59.13 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.609 -0.682 . . . . 73.319999999999993 111.684 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.74 -57.37 12.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.086 0 C-N-CA 124.598 1.159 . . . . 63.439999999999998 107.923 -176.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' THR . . . . . . . . . . . . . 42.9 m -58.22 -37.81 75.57 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 124.575 1.15 . . . . 60.210000000000001 110.979 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' THR . . . . . . . . . . . . . 99.5 m -60.05 -57.24 13.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.628 0.771 . . . . 55.450000000000003 110.054 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -61.78 -42.59 99.18 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.224 0.61 . . . . 73.219999999999999 111.619 -177.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -60.56 -41.29 94.27 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.69 -0.631 . . . . 55.210000000000001 110.777 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' GLY . . . . . . . . . . . . . . . -42.61 -45.69 5.63 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.022 1.296 . . . . 71.430000000000007 112.375 168.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -74.48 -32.17 62.47 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.277 -1.131 . . . . 74.109999999999999 112.069 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.98 -25.91 65.66 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 113.64 0.978 . . . . 72.420000000000002 113.64 174.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.05 -52.82 20.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.128 1.331 . . . . 53.439999999999998 108.435 161.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' SER . . . . . . . . . . . . . 5.8 p 43.69 73.44 0.15 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.207 1.003 . . . . 33.240000000000002 110.301 -159.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--O 1.253 1.254 0 C-N-CA 127.578 2.351 . . . . 51.340000000000003 111.012 -173.758 . . . . . . . . 0 0 . 1 stop_ save_